Skip to Main Content

471

Views

0

CrossRef citations to date

0

Altmetric

Short Communication

Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab

Carrie M Hersh1 Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV 89106, USACorrespondence[email protected]

https://orcid.org/0000-0002-5716-5645 View further author information

,

Menglan Pang2 Biogen, Cambridge, MA 02142, USAView further author information

,

Deborah M Miller3 Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USAView further author information

,

Marisa P McGinley3 Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USAView further author information

,

Megan Hyland4 Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USAView further author information

,

Tjalf Ziemssen5 University Clinic Carl-Gustav Carus, Dresden, 01307, GermanyView further author information

&

Robin L Avila2 Biogen, Cambridge, MA 02142, USAView further author information